• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,190
3,513
3,396
2,816
2,753

COUNTRY

2,360
879
274
262
225

CATEGORIES

  • 950
  • 175
  • 114
  • 293
    • 48
  • 502
  • 257
  • 241
  • 58
  • 62
  • 848
  • 1,504
  • 823
  • 19
  • 495
  • 1,422
  • 2,387
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 269
  • 32
  • 2,624
SHOW ALL…

PRICE

2,454
8,031
16,433
28,942

PUBLISHED

2,515
6,896
12,346
28,942

PRODUCT TYPE

25,986
1,069
1,046
524
163
58
25
21
21
16
6
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Analysis of Barclays plc Analysis of Barclays plc - Product Thumbnail Image

Analysis of Barclays plc

Barclays Plc is a major global financial services company based in London. In 2010, the company was measured as being the tenth largest banking and financials services company in the world by Forbes....

February 2015
FROM
Barclays Plc - SWOT Framework Analysis Barclays Plc - SWOT Framework Analysis - Product Thumbnail Image

Barclays Plc - SWOT Framework Analysis

Barclays Plc is a well known British financial services company, having its presence worldwide. Based in London, the Group is the tenth largest financial services and baking group in the world since...

February 2015
FROM
Analysis of America Movil SAB de CV Analysis of America Movil SAB de CV - Product Thumbnail Image

Analysis of America Movil SAB de CV

Analysis of America Movil SAB de CV. A complete and comprehensive analysis of America Movil SAB de CV, includes an overview of the industry the company operates in, a PEST Framework Analysis of the...

February 2015
FROM
Global Biosimilars Industry 2015 Global Biosimilars Industry 2015 - Product Thumbnail Image

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM
Radiation Induced Nausea and Vomiting (RINV)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Radiation Induced Nausea and Vomiting (RINV)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Radiation Induced Nausea and Vomiting (RINV)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Radiation Induced Nausea and Vomiting (RINV)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Pulmonary Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pulmonary Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pulmonary Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pulmonary Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pulmonary...

February 2015
FROM
Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dermatitis. A...

February 2015
FROM
Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Urinary...

February 2015
FROM
Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Retinoblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Retinoblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Retinoblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Retinoblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Retinoblastoma....

February 2015
FROM
Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Hepatic Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Hepatic Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Hepatic Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Hepatic Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Hepatic Edema....

February 2015
FROM
Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Hemophilia A....

February 2015
FROM
Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chronic...

February 2015
FROM
Chronic Kidney Disease (Chronic Renal Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Chronic Kidney Disease (Chronic Renal Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Chronic Kidney Disease (Chronic Renal Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Chronic Kidney Disease (Chronic Renal Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S